SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950133-02-000520
Filing Date
2002-02-14
Accepted
2002-02-14 00:00:00
Documents
1
Group Members
BB BIOTECH AGBIOTECH INVEST N.V.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT #3 TO SC 13G FOR TRANSKARYOTIC THERAPIES w57602asc13ga.txt SC 13G/A 12740
  Complete submission text file 0000950133-02-000520.txt   14729
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Subject) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-47221 | Film No.: 02549359
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address VODERGASSE 3 SWITZERLAND SCHAFFHAUSEN V8 CH-8300
Business Address VODERGASSE 3 SWITZERLAND SCHAFFHAUSEN V8 CH-8300 411724 59 59
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 0000